Use access key #2 to skip to page content.
$21.48 -0.79 (-3.55%)
9/4/2008 4:00 PM

Amylin Pharmaceuticals, Inc. (AMLN)

CAPS Rating:
***

A biopharmaceutical company committed to improving the lives of people with diabetes, obesity and other diseases through the discovery, development and commercialization of innovative medicines.

View All Commentary (AMLN)

Recs

0

Avatar Matt8265 (90.64) Submitted: 8/16/07 8:25 AM : Outperform Start Price: $44.67 AMLN Score: -33.54

I'm beating Jim Cramer. I sell used cars and do this for 1.5 hours per week.

You invest in his advice.

Think about it.

Report this Post Replies: 0 | Reply

Featured Broker Partners